nuevocor.com | Gene Therapy

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.nuevocor.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Gene Therapy \| Nuevocor \|
Description	Pioneering Novel Gene Therapies for Nuevocor: Pioneering Novel Gene Therapies for
Keywords	N/A

Server Information

WebSite	nuevocor.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

nuevocor.com Valuation

US$1,996,869

Last updated: 2023-05-03 12:06:31

nuevocor.com has Semrush global rank of 5,300,452. nuevocor.com has an estimated worth of US$ 1,996,869, based on its estimated Ads revenue. nuevocor.com receives approximately 230,408 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, nuevocor.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,996,869
Daily Ads Revenue	US$1,844
Monthly Ads Revenue	US$55,298
Yearly Ads Revenue	US$663,575
Daily Unique Visitors	15,361
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
nuevocor.com.	A	599	IP: 185.230.63.171
nuevocor.com.	NS	3600	NS Record: ns35.domaincontrol.com.
nuevocor.com.	NS	3600	NS Record: ns36.domaincontrol.com.
nuevocor.com.	MX	3600	MX Record: 0 nuevocor-com.mail.protection.outlook.com.
nuevocor.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
nuevocor.com.	TXT	3600	TXT Record: v=verifydomain MS=9096209

HtmlToTextCheckTime:2023-05-03 12:06:31

top of page Home About Us Our Focus News Contact A heart transplant is often the only treatment for end-stage heart failure. Rather than giving patients a new heart through a transplant, we aim to do so by developing gene therapies for the treatment of cardiovascular disease. We currently focus on genetic cardiomyopathies characterized by aberrant mechanobiology, which we seek to treat by modulating mechanical force transduction. Headquartered in Singapore, Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts. Nuevocor’s lead program is an adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the lamin A/C ( LMNA ) gene. We plan to address additional currently untreatable autosomal dominant cardiomyopathies using our novel target discovery platform. Our Mission Pioneering Novel Gene

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 25 Oct 2021 18:17:17 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.nuevocor.com/
strict-transport-security: max-age=120
x-wix-request-id: 1635185836.9983371054852614314
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVh0NuQFvpZQ48Kl9xfz/tt3,m0j2EEknGIVUW/liY8BLLvn/1fMuxpYw/Htpcq27vLUa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalgnLvtKTes2rjNnEx0bwCZagqVlJQV/39ihGceQud1zJtS29F5k62W3qYQM/pM31+A==,2UNV7KOq4oGjA5+PKsX47EG2gX3EwxtKlWgE7qSEHjJYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,JLaio/7uvfP647F5CQsGZXCiuXrtuEEb1YPOmPdvr9xGp/J3MBzgzU8QHrQuh4zQ,UvY1uiXtmgas6aI2l+unv5Vm58CgD0xHMJc80N9YKQlHN1TOQvcRbxpN3oqd+GAFKjCWKapddFlOEEDxcGowaw==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 25 Oct 2021 18:17:17 GMT
content-type: text/html; charset=UTF-8
content-length: 423726
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"6d972a70a8871db7704da4de925706b6"
content-language: en
strict-transport-security: max-age=120
age: 5546
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Mon, 25 Oct 2021 16:45:10 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YWiQHDYdb/mh+x60VrcL3mI=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgjB5iMgVduhJkO1xgMq9zO,m0j2EEknGIVUW/liY8BLLhe/Ft074qYAt5jyfc2Z/bHV0TBmJ+uLPQ4OZPC1VSMH,2d58ifebGbosy5xc+FRalriGIP32r/s/4W+4sguZZAPjr7ZM1GG9Z0Pvz1k0HNFhShezBvODBluacyrtmuZ5eA==,2UNV7KOq4oGjA5+PKsX47BkjjUWaXQKmL2j7lKW7y1wfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635185837.2303375317851715672
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131115f5b3a1ba9cdc1a4f5ade9d2efe34139272961f8debdc4088234b26b55341587b7b290f03c843b9ed38fabc5c24637; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

nuevocor.com Whois Information

Domain Name: NUEVOCOR.COM
Registry Domain ID: 2588943303_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-02-03T02:30:10Z
Creation Date: 2021-02-03T02:30:09Z
Registry Expiry Date: 2023-02-03T02:30:09Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS35.DOMAINCONTROL.COM
Name Server: NS36.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T20:55:29Z <<<

nuevocor.com valuation and analysis